Filing metadata

Accession number
0001209191-23-048595
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Sep 07, 2023
Reporting period
Sep 05, 2023
Description
Insider transaction

Explore SEC Filings Hub